Table 5 Antimicrobial agents against MDR pathogens, modified by [49]
From: Treatment of complicated intra-abdominal infections in the era of multi-drug resistant bacteria
| Â | MRSA | VRE | ESBL | Acinetobacter | Pseudomonas aeruginosa |
|---|---|---|---|---|---|
Ampicilin/Sulbactam | Ø | Ø | X | Ø | Ø |
Piperacillin/Sulbactam | Ø | Ø | X | (X) | X |
Glycopeptides (Vancomycin) | (X) | Ø | Ø | Ø | Ø |
Streptogramins (Quinupristin) | X | X | Ø | Ø | Ø |
Lipopeptides (Daptomycin) | X | X | Ø | Ø | Ø |
Oxazolidinones (Linezolid) | X | X | Ø | Ø | Ø |
ß-lactams (Ceftobiprole) | X | (X) | X | X | Ø |
Carbapenemes (Doripenem) | (X) | (X) | X | (X) | X |
Glycylcycline (Tigecycline) | X | X | X | (X) | Ø |
Quinolones | Ø | Ø | (X) | (X) | (X) |